Cytosorbents (CTSO) Inventory Average (2011 - 2026)

Cytosorbents (CTSO) has reported Inventory Average for 15 consecutive years, with $4.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 21.5% year-over-year to $4.1 million; the trailing twelve-month figure through Jun 2026 stood at $4.1 million (up 21.5% YoY), and the FY2025 full-year result was $4.0 million, up 31.38% from the prior year.
• Inventory Average eased to $4.1 million in Q2 2026 per CTSO's latest filing, from $4.9 million in the prior quarter.
• Across five years, Inventory Average topped out at $5.2 million in Q2 2022 and bottomed at $1.9 million in Q2 2023.
• Historically, Inventory Average has averaged $3.7 million across 5 years, with a median of $3.7 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Inventory Average sank 63.82% in 2023, then soared 113.58% in 2024.
• Over 5 years, Inventory Average stood at $3.5 million in 2022, then dropped by 9.28% to $3.2 million in 2023, then retreated by 5.86% to $3.0 million in 2024, then soared by 55.42% to $4.6 million in 2025, then dropped by 12.05% to $4.1 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $4.1 million, $4.9 million, and $4.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.